Detailed Information

Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study

DC Field Value Language
dc.contributor.authorPark, Sue K.-
dc.contributor.authorCho, Lisa Y.-
dc.contributor.authorYang, Jae Jeong-
dc.contributor.authorPark, Boyoung-
dc.contributor.authorLee, Kun-Sei-
dc.contributor.authorYoo, Keun-Young-
dc.contributor.authorLee, Choon-Taek-
dc.contributor.authorKim, Hyeongsu-
dc.contributor.authorChang, Soung Hoon-
dc.identifier.citationLUNG CANCER; Vol.68 1; 20-26ko_KR
dc.description.abstractWe examined whether the strength of the association of cigarette smoking differs according to histological type and gender, and assessed other risk factors, in particular, tuberculosis. We recruited cases from the Korean Academy of Tuberculosis and Respiratory Diseases and controls from Chungju, a local site of the Korean Multi-Center Cancer Cohort. We matched one case to one control for females and two cases to one control for males according to age (<= 44, 45-69, and >= 70 years old). We used unconditional logistic regression to calculate the odds ratio (OR) and 95% confidence interval (Cl) to estimate lung cancer risk by histologic type for males and females separately. The OR (95% Cl) of 40 or more pack-years smoked relative to never smokers was 6.78(4.17-11.00), 3.49(1.83-6.33), and 2.72(1.57-4.72) for males, and 13.72 (3.23-58.18), 12.18(3.12-47.57), and 7.11 (1.78-28.43) for females for squamous cell, adenocarcinoma, and small cell carcinoma, respectively. Among males, the respective OR (95% CI) for past and current history of lung tuberculosis was 3.21 (2.12-4.90), 2.69(1.63-4.45), and 1.52(0.83-2.78), and for females was 2.40 (1.30-4.42), 4.20 (2.75-6.39), and 1.37(0.61-3.06). Our findings provide additional evidence that women are more susceptible to the carcinogenic effects of tobacco, smoking has a higher risk for squamous cell and small cell carcinoma than adenocarcinoma, and tuberculosis is a potential risk factor for certain lung cancer histologic types. (C) 2009 Elsevier Ireland Ltd. All rights reserved.ko_KR
dc.subjectLung cancerko_KR
dc.subjectHistologic typeko_KR
dc.subjectCase-control studyko_KR
dc.subjectGender differenceko_KR
dc.subjectLung tuberculosisko_KR
dc.subjectCigarette smokingko_KR
dc.titleLung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control studyko_KR
dc.citation.journaltitleLUNG CANCER-
dc.description.citedreferenceEngels EA, 2009, INT J CANCER, V124, P1183, DOI 10.1002/ijc.24042-
dc.description.citedreferenceWANG XR, 2009, CANC CAUSES CONTROL-
dc.description.citedreferenceBAE J, 2007, J PREV MED PUBLIC HL, V40, P321-
dc.description.citedreference*KOR NAT STAT OFF, 2006, REP SOC STAT SURV-
dc.description.citedreferenceYun YH, 2005, CANCER EPIDEM BIOMAR, V14, P2125, DOI 10.1158/1055-9965.EPI-05-0236-
dc.description.citedreferencePauk N, 2005, LUNG CANCER-J IASLC, V48, P1, DOI 10.1016/j.lungcan.2004.10.009-
dc.description.citedreferenceTwombly R, 2004, J NATL CANCER I, V96, P898-
dc.description.citedreferenceBain C, 2004, J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143-
dc.description.citedreferenceYang P, 2002, AM J EPIDEMIOL, V156, P1114, DOI 10.1093/aje/kwf153-
dc.description.citedreferenceSobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308-
dc.description.citedreferencePARKIN DM, 2002, CA CANC J CLIN, V55, P74-
dc.description.citedreferenceBAE JM, 2002, CANC RES TREAT, V34, P77-
dc.description.citedreferenceYOO KY, 2002, ASIAN PAC J CANCER P, V3, P85-
dc.description.citedreference*KOR NAT STAT OFF, 2002, ANN REP CAUS DEATH S-
dc.description.citedreferenceBrenner AV, 2001, INT J EPIDEMIOL, V30, P118-
dc.description.citedreferenceKhuder SA, 2001, LUNG CANCER-J IASLC, V31, P139-
dc.description.citedreferenceLee CT, 2000, LUNG CANCER-J IASLC, V30, P15-
dc.description.citedreferenceJee SH, 1999, INT J EPIDEMIOL, V28, P824-
dc.description.citedreferencePrescott E, 1998, EPIDEMIOLOGY, V9, P79-
dc.description.citedreferenceZang EA, 1996, J NATL CANCER I, V88, P183-
dc.description.citedreferenceTHUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223-
dc.description.citedreferenceTAIOLI E, 1994, J NATL CANCER I, V86, P869-
dc.description.citedreferenceKOBAYASHI Y, 1994, BBA-GEN SUBJECTS, V1200, P11-
dc.description.citedreferenceOHSHIMA H, 1994, MUTAT RES, V305, P253-
dc.description.citedreferenceRISCH HA, 1993, AM J EPIDEMIOL, V138, P281-
dc.description.citedreferenceAOKI K, 1993, JPN J CLIN ONCOL, V23, P205-
dc.description.citedreferenceVANDEWIEL JAG, 1992, BIOCHEM PHARMACOL, V44, P1977-
dc.description.citedreferenceBROWNSON RC, 1992, EPIDEMIOLOGY, V3, P61-
dc.description.citedreferencePIEKOSZEWSKI W, 1991, ACTA POL PHARM, V48, P9-
dc.description.citedreference*KOR NAT STAT OFF, 1990, REP SOC STAT SURV-
dc.description.citedreferenceYANG CP, 1989, J NATL CANCER I, V81, P1828-
dc.description.citedreferenceADAMI HO, 1989, INT J CANCER, V44, P833-
dc.description.citedreferenceKYEREMATEN GA, 1988, DRUG METAB DISPOS, V16, P823-
dc.description.citedreferenceGAO YT, 1987, INT J CANCER, V40, P604-
dc.description.citedreferenceZHENG W, 1987, BRIT J CANCER, V56, P501-
dc.description.citedreferenceBENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499-
dc.description.citedreferenceLUBIN JH, 1984, J NATL CANCER I, V73, P383-
dc.description.citedreferenceCHAUDHURI PK, 1982, CANCER LETT, V16, P327-
dc.description.citedreferenceAUERBACH O, 1979, CANCER, V43, P636-
dc.description.citedreferenceDOLL R, 1976, BRIT MED J, V2, P1525-
dc.description.citedreferenceROSECRAN.JA, 1972, ARCH INT PHARMACOD T, V196, P46-
dc.description.citedreferenceRAEBURN C, 1957, BRIT J TUBERC DIS CH, V51, P237-
Appears in Collections:
Files in This Item:
There are no files associated with this item.


Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.